Projects per year
Search results
-
Active
Bridging the gap between urinary tract infection pharmacokinetic/pharmacodynamic in vitro models and the optimization of antibiotic selection, dosing strategies, clinical breakpoints, and novel drug development
Abbott, I., Peleg, A., Landersdorfer, C., Bradshaw, C., Meletiadis, J., Huttner, A. & Patel, R.
United States Food and Drug Administration
29/09/23 → 28/09/26
Project: Research
-
MMQPA: Monash-Moderna Quantitative Pharmacology Accelerator
Kirkpatrick, C., Landersdorfer, C. & Porter, C.
Monash University – Internal University Contribution
15/08/23 → 14/08/28
Project: Research
-
Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND)
Roberts, J. A., Slavin, M. A., Paterson, D. L., Comans, T. A., Lipman, J., Landersdorfer, C., Joynt, G., Bellomo, R., Clark, J. & Parker , S.
1/01/22 → 31/12/26
Project: Research
-
Antibacterial Material Design via Mechanism-Based Mathematical Modelling
Whittaker, M., Landersdorfer, C. & Velkov, T.
31/01/20 → 31/12/23
Project: Research
-
Novel dosing regimens to maximise antibiotic effectiveness for treatment of pneumonia in the intensive care unit
Roberts, J. A., Lipman, J., De Waele, J., Koulenti, D. & Landersdorfer, C.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/23
Project: Research
-
Overcoming multidrug-resistant hypermutable Pseudomonas aeruginosa via antibiotic combinations
Landersdorfer, C., Oliver, A., Harper, M. & Nation, R.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/23
Project: Research